Related Experiment Video
Updated: Jun 29, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Associations Between Resolvin D1 and Culprit Plaque Morphologies: An Optical Coherence Tomography Study in Patients
Runzhen Chen1,2, Jiannan Li1,3, Zhaoxue Sheng4
1Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Insights
High levels of resolvin D1 (RvD1) are linked to unstable coronary plaques in patients with ST-segment elevation myocardial infarction (STEMI). This suggests RvD1 may play a role in plaque rupture and calcification, indicating increased cardiovascular risk.
Area of Science:
- Cardiovascular Research
- Lipid Mediators
- Atherosclerosis Pathophysiology
Background:
- Resolvin D1 (RvD1) is a pro-resolving lipid mediator known to inhibit atherosclerosis by reducing oxidative stress and inflammation.
- The specific role of RvD1 in human coronary artery disease, particularly in ST-segment elevation myocardial infarction (STEMI), remains largely uncharacterized.
Purpose of the Study:
- To investigate the association between plasma levels of RvD1 and the characteristics of culprit plaques in patients diagnosed with STEMI.
- To determine if RvD1 levels correlate with specific plaque morphologies indicative of instability.
Main Methods:
- Analysis of 240 STEMI patients who underwent optical coherence tomography (OCT).
- Quantification of plasma RvD1 levels using enzyme-linked immunosorbent assay (ELISA).
- Application of logistic regression and receiver operating curve (ROC) analysis to assess associations and identify predictive thresholds.
Main Results:
- The median plasma RvD1 level was 129.7 pg/mL.
- Elevated RvD1 levels (≥111.5 pg/mL) were significantly associated with plaque rupture (OR: 2.09).
- Higher RvD1 concentrations correlated with healed plaques (≥246.4 pg/mL, OR: 2.17) and calcification (≥293.38 pg/mL, OR: 2.10).
Conclusions:
- Increased plasma RvD1 levels are associated with more unstable coronary atherosclerotic plaques in STEMI patients.
- These findings suggest RvD1 may be a biomarker for plaque vulnerability and a potential therapeutic target in managing coronary artery disease.
Background:
As a specialized pro-resolving lipid mediator, resolvin D1 (RvD1) inhibits atherosclerosis progression in vivo by reducing regional oxidative stress and chronic inflammation. However, it is unclear how RvD1 is involved in human coronary artery disease. This study aims to investigate the association between plasma levels of RvD1 and culprit-plaque characteristics in patients with ST-segment elevation myocardial infarction (STEMI).
Methods:
A total of 240 STEMI patients undergoing optical coherence tomography (OCT) examination were analyzed. RvD1 levels were measured in patient plasma samples using an enzyme-linked immunosorbent assay. Logistic regression was performed to assess the association between RvD1 levels and various culprit plaque morphologies, and the receiver operating curve was used to search for an optimal cutoff threshold to predict certain pathological features.
Results:
The median RvD1 level was 129.7 (56.6-297.8) pg/mL. According to multivariable logistic regression, high RvD1 was associated with plaque rupture (≥111.5 pg/mL, odds ratio [OR]: 2.09, 95% confidence interval [CI]: 1.20-3.66, P = 0.010), healed plaques (≥246.4 pg/mL, OR: 2.17, 95% CI: 1.11-4.24, P = 0.023), and calcification (≥293.38 pg/mL, OR: 2.10, 95% CI: 1.21-3.66, P = 0.008) at culprit lesions.
Conclusion:
Increased levels of RvD1 were associated with higher instability of coronary atherosclerotic plaques in STEMI patients.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies

